Swedish Inflammatory Bowel Disease Register (SWIBREG) – a nationwide quality register

References

• Ludvigsson JF, Busch K, Olen O, et al. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study. BMC Gastroenterol. 2017;17(1):23.
   PubMed Web of Science ®Google Scholar
• Olen O, Askling J, Sachs MC, et al. Increased mortality of patients with childhood-onset inflammatory bowel diseases, compared with the general population. Gastroenterology. 2019;156(3):614–622.
   PubMed Web of Science ®Google Scholar
• Olen O, Askling J, Sachs MC, et al. Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964–2014. BMJ. 2017;358:j3951.
   PubMed Web of Science ®Google Scholar
• Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504–1517.
   PubMed Web of Science ®Google Scholar
• Everhov AH, Halfvarson J, Myrelid P, et al. Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden. Gastroenterology. 2018;154(3):518–528 e15.
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778.
   PubMed Web of Science ®Google Scholar
• Parkes GC, Whelan K, Lindsay JO. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis. 2014;8(8):717–725.
   PubMed Web of Science ®Google Scholar
• Imhann F, Vich Vila A, Bonder MJ, et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. 2018;67(1):108–119.
   PubMed Web of Science ®Google Scholar
• Ortqvist AK, Lundholm C, Halfvarson J, et al. Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study. Gut. 2019;68(2):218–225.
   PubMed Web of Science ®Google Scholar
• Shah SC, Khalili H, Gower-Rousseau C, et al. Sex-based differences in incidence of inflammatory bowel diseases-pooled analysis of population-based studies from western countries. Gastroenterology. 2018;155(4):1079–1089 e3.
   PubMed Web of Science ®Google Scholar
• Ellinghaus D, Bethune J, Petersen BS, et al. The genetics of Crohn's disease and ulcerative colitis–status quo and beyond. Scand J Gastroenterol. 2015;50(1):13–23.
   PubMed Web of Science ®Google Scholar
• Silverman SL. From randomized controlled trials to observational studies. Am J Med. 2009;122(2):114–120.
   PubMed Web of Science ®Google Scholar
• Swedish Patient Data Law (Patientdatalagen). 355. Sect. 7 2008.
   Google Scholar
• Emilsson L, Lindahl B, Koster M, et al. Review of 103 Swedish Healthcare Quality Registries. J Intern Med. 2015;277(1):94–136.
   PubMed Web of Science ®Google Scholar
• Munkholm P. Crohn's disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull. 1997;44(3):287–302.
   PubMed Web of Science ®Google Scholar
• Langholz E. Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull. 1999;46(5):400–415.
   PubMed Web of Science ®Google Scholar
• Jakobsson GL, Sternegard E, Olen O, et al. Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG). Scand J Gastroenterol. 2017;52(2):216–221.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Haberg SE, Knudsen GP, et al. Ethical aspects of registry-based research in the Nordic countries. Clin Epidemiol. 2015;7:491–508.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749–753.
   PubMed Web of Science ®Google Scholar
• Magro F, Gionchetti P, Eliakim R, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and Ileo-anal Pouch disorders. J Crohns Colitis. 2017;11(6):649–670.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667.
   PubMed Web of Science ®Google Scholar
• Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17(6):1314–1321.
   PubMed Web of Science ®Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625–1629.
   PubMed Web of Science ®Google Scholar
• Froslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133(2):412–422.
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735.
   PubMed Web of Science ®Google Scholar
• Olen O, Askling J, Sachs MC, et al. Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964–2014. Gut. 2019. DOI:10.1136/gutjnl-2018-317572
   Web of Science ®Google Scholar
• Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997;337(15):1029–1035.
   PubMed Web of Science ®Google Scholar
• Eriksson C, Marsal J, Bergemalm D, et al. Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG). Scand J Gastroenterol. 2017;52(6–7):722–729.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Feagan BG, Rutgeerts P, et al. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med. 2013;369(8):711–721.
   PubMed Web of Science ®Google Scholar
• Feagan BG, Rutgeerts P, Sands BE, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;369(8):699–710.
   PubMed Web of Science ®Google Scholar
• Umanskiy K, Fichera A. Health related quality of life in inflammatory bowel disease: the impact of surgical therapy. World J Gastroenterol. 2010;16(40):5024–5034.
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Dignass A, Danese S, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: surgical management and special situations. J Crohns Colitis. 2017;11(2):135–149.
   PubMed Web of Science ®Google Scholar
• Mark-Christensen A, Erichsen R, Brandsborg S, et al. Pouch failures following ileal pouch-anal anastomosis for ulcerative colitis. Colorectal Dis. 2018;20(1):44–52.
   PubMed Web of Science ®Google Scholar
• Nordenvall C, Myrelid P, Ekbom A, et al. Probability, rate and timing of reconstructive surgery following colectomy for inflammatory bowel disease in Sweden: a population-based cohort study. Colorectal Dis. 2015;17(10):882.
   PubMed Web of Science ®Google Scholar
• Cnattingius S, Ericson A, Gunnarskog J, et al. A quality study of a medical birth registry. Scand J Soc Med. 1990;18(2):143–148.
   PubMedGoogle Scholar
• Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12(4):205–217.
   PubMed Web of Science ®Google Scholar
• Jaghult S, Saboonchi F, Johansson UB, et al. Identifying predictors of low health-related quality of life among patients with inflammatory bowel disease: comparison between Crohn's disease and ulcerative colitis with disease duration. J Clin Nurs. 2011;20(11–12):1578–1587.
   PubMed Web of Science ®Google Scholar
• Stjernman H, Granno C, Jarnerot G, et al. Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflamm Bowel Dis. 2008;14(1):47–52.
   PubMed Web of Science ®Google Scholar
• McDermott E, Keegan D, Byrne K, et al. The Short Health Scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients. J Crohns Colitis. 2013;7(8):616–621.
   PubMed Web of Science ®Google Scholar
• Hjortswang H, Jarnerot G, Curman B, et al. The Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol. 2006;41(10):1196–1203.
   PubMed Web of Science ®Google Scholar
• Abdovic S, Pavic AM, Milosevic M, et al. Short health scale: a valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(4):818–823.
   PubMed Web of Science ®Google Scholar
• Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43(1):29–32.
   PubMed Web of Science ®Google Scholar
• Harvey RF, Bradshaw MJ. Measuring Crohn's disease activity. Lancet. 1980;1(8178):1134–1135.
   PubMed Web of Science ®Google Scholar
• Mason A, Malik S, McMillan M, et al. A prospective longitudinal study of growth and pubertal progress in adolescents with inflammatory bowel disease. Horm Res Paediatr. 2014;83(1):45–54.
   PubMed Web of Science ®Google Scholar
• Malmborg P, Grahnquist L, Idestrom M, et al. Presentation and progression of childhood-onset inflammatory bowel disease in Northern Stockholm County. Inflamm Bowel Dis. 2015;21(5):1098–1108.
   PubMed Web of Science ®Google Scholar
• Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135(4):1114–1122.
   PubMed Web of Science ®Google Scholar
• Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology. 2008;135(4):1106–1113.
   PubMed Web of Science ®Google Scholar
• Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2009;104(8):2080–2088.
   PubMed Web of Science ®Google Scholar
• Pigneur B, Seksik P, Viola S, et al. Natural history of Crohn's disease: comparison between childhood- and adult-onset disease. Inflamm Bowel Dis. 2010;16(6):953–961.
   PubMed Web of Science ®Google Scholar
• Sebastian S, Jenkins H, McCartney S, et al. The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: differing perceptions from a survey of adult and paediatric gastroenterologists. J Crohns Colitis. 2012;6(8):830–844.
   PubMed Web of Science ®Google Scholar
• Ruemmele FM, Veres G, Kolho KL, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis. 2014;8(10):1179–1207.
   PubMed Web of Science ®Google Scholar
• Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007;(1):CD000542.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Svedberg P, Olen O, et al. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423–437.
   PubMed Web of Science ®Google Scholar
• Batalden M, Batalden P, Margolis P, et al. Coproduction of healthcare service. BMJ Qual Saf. 2016;25(7):509–517.
   PubMed Web of Science ®Google Scholar
• Batalden PB, Davidoff F. What is “quality improvement” and how can it transform healthcare? Qual Saf Health Care. 2007;16(1):2–3.
   PubMed Web of Science ®Google Scholar
• Ovretveit J, Keller C, Hvitfeldt Forsberg H, et al. Continuous innovation: developing and using a clinical database with new technology for patient-centred care – the case of the Swedish quality register for arthritis. Int J Qual Health Care. 2013;25(2):118–124.
   PubMed Web of Science ®Google Scholar
• Rejler M. Nätverk förbättrar vården för patienter med kroniska sjukdomar; 2014. Hälsohögskolan, Högskolan i Jönköping, HHJ. Kvalitetsförbättring och ledarskap inom hälsa och välfärd Stockholm: Sweden, Europe. [cited 2019 Aug 29]. Available from: http://hj.diva-portal.org/smash/get/diva2:781567/FULLTEXT01.pdf
   Google Scholar
• Rundquist S, Eriksson C, Nilsson L, et al. Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG). Scand J Gastroenterol. 2018;53(10–11):1257–1263.
   PubMed Web of Science ®Google Scholar
• IBD standards: Benchmarking tool. [cited 2019 Aug 12]. Available from: https://ibduk.org/ibd-benchmarking-tool
   Google Scholar
• Maly RC, Liu Y, Liang LJ, et al. Quality of life over 5 years after a breast cancer diagnosis among low-income women: effects of race/ethnicity and patient-physician communication. Cancer. 2015;121(6):916–926.
   PubMed Web of Science ®Google Scholar
• Rubin DT, Dubinsky MC, Martino S, et al. Communication between physicians and patients with ulcerative colitis: reflections and insights from a qualitative study of in-office patient-physician visits. Inflamm Bowel Dis. 2017;23(4):494–501.
   PubMed Web of Science ®Google Scholar
• Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010;362(15):1383–1395.
   PubMed Web of Science ®Google Scholar
• Zankel E, Rogler G, Andus T, et al. Crohn's disease patient characteristics in a tertiary referral center: comparison with patients from a population-based cohort. Eur J Gastroenterol Hepatol. 2005;17(4):395–401.
   PubMed Web of Science ®Google Scholar
• Everhov AH, Khalili H, Askling J, et al. Work loss before and after diagnosis of Crohn's disease. Inflamm Bowel Dis. 2019;25(7):1237–1247.
   PubMed Web of Science ®Google Scholar
• Everhov AH, Khalili H, Askling J, et al. Sick leave and disability pension in prevalent patients with Crohn's disease. J Crohns Colitis. 2018;12(12):1418–1428.
   PubMed Web of Science ®Google Scholar
• Lichtenstein GR. The TREAT Registry: evolution of knowledge from 1999 to 2017: lessons learned. Clin Gastroenterol Hepatol. 2017;15(9):1319–1321.
   PubMed Web of Science ®Google Scholar
• Hetland ML, Unkerskov J, Ravn T, et al. Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO). Scand J Rheumatol. 2005;34(1):40–44.
   PubMed Web of Science ®Google Scholar
• Bardhan KD, Simmonds N, Royston C, et al. A United Kingdom inflammatory bowel disease database: making the effort worthwhile. J Crohns Colitis. 2010;4(4):405–412.
   PubMed Web of Science ®Google Scholar
• Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet. 2001;357(9262):1093–1094.
   PubMed Web of Science ®Google Scholar
• Taylor L, Casson D, Platt MJ. Issues and experience around the Paediatric Register of Inflammatory Bowel Disease. Arch Dis Child. 2003;88(10):891–893.
   PubMed Web of Science ®Google Scholar